Skip to main content

Hypoglycaemia with insulin aspart: a double‐blind, randomised, crossover trial in subjects with Type 1 diabetes

Buy Article:

$43.00 plus tax (Refund Policy)

Aims  To compare the effects of the rapid‐acting insulin analogue insulin aspart and soluble human insulin on hypoglycaemia and glycaemic control in patients with Type 1 diabetes when injected immediately before meals as part of intensive insulin therapy.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Type 1 diabetes; clinical trial; double‐blind; hypoglycaemia; insulin aspart

Document Type: Research Article

Affiliations: 1: Northern General Hospital, Sheffield, UK 2: Prince of Wales Hospital, Randwick, Australia 3: Solli Klinikk, Jessheim, Norway 4: Department of Endocrinology, University Hospital Groningen, the Netherlands 5: Diabetes out-patient clinic, Roskilde county hospital, Køge, Denmark 6: Novo Nordisk A/S, Bagsværd, Denmark and 7: Novo Nordisk Ltd, Crawley, UK

Publication date: 01 July 2004

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more